| Tara L Carlson, PA-C | |
|
890 Lazelle St, Sturgis, SD 57785 | |
| (605) 720-2600 | |
| (605) 720-2611 |
| Full Name | Tara L Carlson |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 19 Years |
| Location | 890 Lazelle St, Sturgis, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215978382 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 0604 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monument Health Rapid City Hospital | Rapid city, SD | Hospital |
| Monument Health Sturgis Hospital | Sturgis, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Monument Health Rapid City Hospital, Inc. | 6002729506 | 424 |
News Archive
John Theurer Cancer Center at Hackensack University Medical Center announced today that it is one of two cancer centers in the tri-state area currently implanting a wireless radiation sensor, known as DVS. John Theurer Cancer Center radiation oncologists can now receive data immediately post- treatment on the precise amount of radiation being delivered to tumors and surrounding tissue for prostate cancer treatments.
AspenBio Pharma, Inc., an emerging bio-science company dedicated to the development of novel diagnostics and drugs for humans and animals, reported on its progress and plans for the Premarket Notification 510(k) submission of its ELISA format AppyScore™ test. AppyScore is the first blood-based test designed to aid in the evaluation of patients suspected of having acute appendicitis.
You can't avoid H1N1 media coverage. It's front-page news on the web, the presses, the airways. Vaccine details, or lack of, are spurring discussion and debate. And a lot of people are in a quandary about whether or not to have the H1N1 shot based on their personal views and the information disseminated for public knowledge.
An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customized for each individual patient, and was developed by Dr. J-P. Routy from the Research Institute of the MUHC in collaboration with Dr. R. S-kaly from the Universit- de Montr-al.
Eli Lilly and Company today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tara L Carlson, PA-C 353 Fairmont Blvd, Atten Medical Staff Services, Rapid City, SD 57701-6000 Ph: () - | Tara L Carlson, PA-C 890 Lazelle St, Sturgis, SD 57785 Ph: (605) 720-2600 |
News Archive
John Theurer Cancer Center at Hackensack University Medical Center announced today that it is one of two cancer centers in the tri-state area currently implanting a wireless radiation sensor, known as DVS. John Theurer Cancer Center radiation oncologists can now receive data immediately post- treatment on the precise amount of radiation being delivered to tumors and surrounding tissue for prostate cancer treatments.
AspenBio Pharma, Inc., an emerging bio-science company dedicated to the development of novel diagnostics and drugs for humans and animals, reported on its progress and plans for the Premarket Notification 510(k) submission of its ELISA format AppyScore™ test. AppyScore is the first blood-based test designed to aid in the evaluation of patients suspected of having acute appendicitis.
You can't avoid H1N1 media coverage. It's front-page news on the web, the presses, the airways. Vaccine details, or lack of, are spurring discussion and debate. And a lot of people are in a quandary about whether or not to have the H1N1 shot based on their personal views and the information disseminated for public knowledge.
An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customized for each individual patient, and was developed by Dr. J-P. Routy from the Research Institute of the MUHC in collaboration with Dr. R. S-kaly from the Universit- de Montr-al.
Eli Lilly and Company today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.
› Verified 3 days ago
Sarah Lynn Fitzsimmons, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 890 Lazelle St, Sturgis, SD 57785 Phone: 605-720-2600 Fax: 605-720-2601 | |
Randa S Johnson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 949 Harmon St, Sturgis, SD 57785 Phone: 605-720-2400 Fax: 605-720-0338 | |
Kristen M Legner, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 890 Lazelle St, Sturgis, SD 57785 Phone: 605-720-2600 Fax: 605-720-2611 | |
Michael S Messmer, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 890 Lazelle St, Sturgis, SD 57785 Phone: 605-720-2600 Fax: 605-720-2611 |